Viskase Holdings inc (ENZN) Annual Balance Sheets

Annual · GAAP · USD millions
Access ENZN quarterly Balance Sheets →
Looking at balance sheet data from Viskase Holdings inc through Dec 31 2021 provides insight into Dec 31 2025's solvency and capital structure over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent42.57
Cash & Short-term Investments42.00
Other Current Assets0.24
Total Current Assets42.81
Other Assets, Noncurrent0.00
Milestone Receivable On Royalties Current-
Deferred Income Tax Assets Net-
Total Assets42.81
Liabilities
Accounts Payable, Current AC0.33
Accrued Liabilities, Current AC0.40
Other Liabilities, Current0.00
Total Current Liabilities0.73
Total Long-term Debt0.00
Accrued Rent, Noncurrent0.00
Total Liabilities0.73
Stockholders' Equity
Common Stock Value0.74
Additional Paid In Capital Common Stock70.03
Retained Earnings / Accumulated Deficit-73.30
Other Equity-44.61
Common Stockholder's Equity-47.13
Non-controlling interests & other44.61
Total Stockholder's Equity-2.52
Liabilities & Stockholder's Equity42.81
4 historic quarters locked

Sign in to unlock the full Viskase Holdings inc balance sheet history.

About Enzon Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-022313

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License